ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ACHP Asia Ceramics

37.50
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Asia Ceramics LSE:ACHP London Ordinary Share JE00B3PVQ001 ORD 0.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 37.50 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Asia Ceramics Share Discussion Threads

Showing 1501 to 1518 of 1825 messages
Chat Pages: Latest  61  60  59  58  57  56  55  54  53  52  51  50  Older
DateSubjectAuthorDiscuss
13/9/2023
16:49
PwC partners sacrifice payouts to invest £100m in AI technology
hazl
13/9/2023
16:38
Insig AI Director dealings
Trade date Director Volume / Price Trade value Trade type
29/08/2023 Richard Bernstein 100,000 @ 18.00p £18,000.00 Buy
23/08/2023 Richard Bernstein 50,050 @ 18.50p £9,259.25 Buy
18/08/2023 Richard Bernstein 116,944 @ 18.32p £21,424.14 Buy
14/08/2023 Richard Bernstein 150,000 @ 15.71p £23,565.00 Buy
18/05/2023 Richard Bernstein 153,497 @ 18.35p £28,166.70 Buy
10/05/2023 Richard Bernstein 205,000 @ 23.74p £48,667.00 Buy
27/04/2023 Richard Bernstein 100,000 @ 19.00p £19,000.00 Buy
13/01/2023 Richard Bernstein 200,000 @ 15.00p £30,000.00 Buy
23/12/2022 Richard Bernstein 70,000 @ 16.00p £11,200.00 Buy
22/12/2022 Richard Bernstein 380,000 @ 13.66p £51,908.00 Buy

hazl
13/9/2023
12:22
The 2023 EMEA PR Consultancies of the Year are the result of an exhaustive research process involving more than 200 submissions and meetings with the best PR firms across the UK, Europe the Middle East and Africa. Analysis of each of the Winners and finalists across 20 geographic and specialist categories can be accessed via the navigation menu to the right or below. Winners are unveiled at the 2023 EMEA SABRE Awards.

Look at how far and wide this extends to and Blurred won it!

Must be the strength of their partnership with Insig AI!

hazl
13/9/2023
12:20
Look who won agency of the year!

Blurred!

And who are they partnered with ?

Insig AI!

hazl
13/9/2023
09:43
Blurred connections to INSG .
hazl
13/9/2023
09:38
INSG






We call this ESGP. You can also call it just good business strategy. Reducing negative impacts through ESG and creating positive impact by acting according to a best-practice Purpose. A net-gain for people and planet. Protecting value at risk and creating value – real value, for all stakeholders. ESG isn’t a siloed data reporting exercise and Purpose is not a brand exercise. Together they are a strategy for impact.

Beginning with major research* by Said Business School, University of Oxford, which revealed how strongly institutional investors want to see Purpose and ESG integrated at company Board level, and in partnership with AI and data solutions firm Insig.ai, Blurred has created its own proprietary methodology for assessing and scoring how well a public company integrates ESG and Purpose, in terms of narrative, foundations and governance.

Our initial report in to The Impact Gap, which assessed the entire FTSE100, was published in April 2023 and can be downloaded here. The full slideshow from our launch presentation is viewable at the bottom of this page.

Headline findings of our research include:

Less than half of FTSE100 businesses demonstrate progress towards best-practice Purpose

Market leaders are not who you might think: FMCG brands are laggards when it comes to Purpose and ESGP integration; mining and manufacturing companies lead the way

Larger market-cap companies under-index on Purpose communication

The average FTSE100 business scores just 5.5/10 on ESG and Purpose integration

hazl
13/9/2023
09:33
Blurred

“We’ve partnered with Insig AI to better understand the data around public company ESG reporting and disclosure. The Insig team and product has been invaluable.”
– Stuart Lambert, Co-Founder and Chief Strategy Officer, Blurred


INSG

hazl
12/9/2023
16:04
I wonder if hazl keeps a diary hidden away in one of these threads.
millennialinvestor
12/9/2023
15:22
A reading along those lines would be much lower than the CPI’s June 2022 peak of 9.1% but still well above the Fed’s 2% target rate.

On Thursday, the Producer Price Index, which tracks the average change in prices that businesses pay to suppliers, is expected to show an annual increase of 1.2%, up from 0.8% last month.

If inflation readings this week come in below those estimates, that could signal to traders that the Fed has hit its peak interest rate and will not hike further, said Jason Pride and Michael Reynolds of Glenmede, an investment and private wealth management firm. But if inflation proves stronger than expected, additional rate hikes could come later this year leading to more market indecision and volatility.

Financial markets see more than a 90% chance that Fed officials will vote for a pause at their policy meeting on Sept. 19-20, according to the CME FedWatch tool, but investors’ bets of another pause in November are lower, at around 54%.

A resilient labor market and forecasts of strong economic growth this quarter mean that inflation may stay higher for longer, prompting more fears that additional Fed rate hikes are on the way


CNN

hazl
12/9/2023
15:03
I have to say that most will simply scroll past boards where one poster continues to post to themselves .
Unless it is relevant info or an archive thread , eg my “ drunken loser “ thread on RKH where I place all Gozzas bilious posts for all to see .

Hazl, if you lose to Millstone or ( Millen ) as you put it , the name HAZL will be black marked.
It’s impossible to regain one’s reputation once BLACK MARKED .

melegramforttongo
12/9/2023
13:05
Welcome millennial!

I bet not many say that to you.

Ha ha.

8-)

hazl
12/9/2023
11:19
deeply disturbing posting to yourself day and night. get help
millennialinvestor
10/9/2023
19:11
Also
Andrada Mining is bordering on breakeven, according to some British Metals and Mining analysts. They expect the company to post a final loss in 2024, before turning a profit of UK£24m in 2025. The company is therefore projected to breakeven around 2 years from today.21 Mar 2023

hazl
09/9/2023
12:25
Carbon Nanotube Electrodes. Available next year 2023 is the carbon nanotube battery. This battery boasts of vertically aligned carbon nanotubes that can boost battery power 10 times compared to other battery packs. In addition, it has three times energy storage and five times increase in the battery lifecycle.31 Mar 2023

The future of electric vehicle batteries: What's on the horizon?
Interplex
› the-future-of-electric-vehicle-batt...

hazl
08/9/2023
14:21
Hannam note 358% 33p6 Sep 2023 19:20

Andrada Mining (“ATM”) has released assay results for the first batch of Reverse Circulation (”RC”) exploration drilling results undertaken at the ATNN01 – ATNN14 pegmatites, within licence ML133, also known as the Lithium Ridge Project. Situated ~35km SE of ATM’s flagship Uis Mine, an exploration drilling programme comprised of 24 RC drill holes was implemented to investigate the continuation of selected outcropping lithium-enriched pegmatites at depth. The programme yields ~800 chemical analysis samples with the results of the first 14 holes, comprising ~400 samples reported in the recent announcement. The programme was designed to investigate the subsurface morphology and metal endowment of pegmatites containing elevated lithium values at the surface. Results confirm lithium mineralisation along the 4km strike distance covered and indicate intersections at higher lithium grades compared to those at Uis (~0.72%) with a weighted average grade of ~1.06% Li2O. Weighted average tantalum grades of ~79ppm were in line with Uis’ ~86ppm. The company’s offsite metallurgical programme has shown the ability to produce a saleable petalite concentrate from Lithium Ridge. Together with the ongoing commissioning of the lithium pilot plant at Uis, balance sheet de-risking post recent convertible note and bank loan financings, and a strategic process still to be concluded to select a funding partner to participate in the acceleration of the Company's lithium development, we believe the 78% discount to our GBp 33/sh target price should continue to close. More evidence of potential for Lithium Ridge to supplement Uis petalite output Out of the 14 holes covered in the announcement, highlights include ATNN 08, which intersected 14m at 1.80% Li2O, 0.08% Sn and 70 ppm Ta from a depth of 8m, including an 11m subinterval at 2.13% Li2O, and hole ATNN 02 which intersected 27 m at 1.24% Li2O, 0.14% Sn and 116 ppm Ta from a depth of 31m to 58m. License ML133 is situated along the D1903 road linking to the B2 highway and sits within ‘truckableR17; distance from existing processing facilities at Uis, where a pilot lithium circuit has been constructed. The company expects the remaining 10 drilling holes to show similar results in line with the channel samples over the remaining 2km mineralised strike distance. With successful results achieved through the programme, it is probable that ATM will undertake further drilling initiatives aiming to establish a JORC-compliant resource within this area of the licence in future. Lithium pilot plant commissioning being “finalisedR21; As detailed in our June 12th upgrade note, ATM produced the first saleable bulk lithium concentrate from the off-site pilot test, processing material from Lithium Ridge using dense medium separation ("DMS"). This petalite concentrate is being tested for conversion to lithium carbonate and lithium hydroxide. Additional beneficiation steps available to ATM include froth flotation and sensor-

Thanks to ATM Jelignite.

hazl
08/9/2023
09:20
Sep 07, 2023 | staff reporter

NEW YORK – Genedrive announced on Thursday that its point-of-care pharmacogenomic test to determine treatment response in stroke patients has received UK Conformity Assessed marking registration.

The Genedrive CYP2C19 System can be used to determine which stroke patients are likely to respond to clopidogrel treatment by testing for six genetic variants of the CYP2C19 gene that affect the loss of metabolism function and poor activation of clopidogrel, the company said in a statement. The system automatically interprets information for the clinician and returns results in about one hour from a cheek swab sample.

"The use of point-of-care testing allows patients to be put on an optimized treatment plan as quickly as possible," Genedrive CEO David Budd said in a statement. "The risk of recurrent stroke in the week after a [transient ischemic attack] or minor stroke is up to 10 percent, so routine laboratory testing which can take many days or weeks is unlikely to be as appropriate as a point-of-care solution returning results in about one hour."

In performance evaluations, the test was 99 percent accurate in detecting the variants that affect loss of metabolism function, the company said. The UKCA marking will allow the company to begin commercializing the test in the UK and engaging in the DEVOTE program, which will generate further data in an acute care setting, it added. The expanded dataset is required to submit the test for CE marking, which is expected in the first half of 2024.

Draft guidance from the UK's National Institute for Health and Care Excellence released earlier this year recommended that people who have had an ischemic stroke or transient ischemic attack should have a CYP2C19 genetic test before receiving treatment. The final recommendations are expected to be released in December, which Genedrive said it expects to drive momentum for adoption of its test.

hazl
07/9/2023
18:06
John McDermott
@John_H_McD
⚡️Rapid CYP2C19 genotyping - we're looking forward to ongoing implementation via the @DEVOTEProgramme
.

🤝Developed by @genedriveplc
with @MFTnhs
, @NWGLH
, @HealthInnovMcr
, and @EGS_UoM
.

🏆Funded by @innovateuk
, @ManchesterBRC
, and @wellcometrust
.

hazl
07/9/2023
18:04
The UK-based point of care molecular diagnostics company announced has secured UKCA marking registration for its Genedrive CYP2C19 System, a rapid genetic test that can identify how patients will respond to the common anti-platelet drug clopidogrel that is used to help prevent secondary strokes.
hazl
Chat Pages: Latest  61  60  59  58  57  56  55  54  53  52  51  50  Older

Your Recent History

Delayed Upgrade Clock